| Source: |
| Type: measurement |
| Bioavailability (usually in %) absorbed by the body. |
| 6085- | CHOC, | Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model |
| - | in-vivo, | PC, | NA |
| 6098- | Chol, | Choline |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 6095- | Chol, | Choline metabolism and its implications in cancer |
| - | Review, | Var, | NA |
| 6131- | CHr, | Bor, | Z, | Fabrication of phenyl boronic acid modified pH-responsive zinc oxide nanoparticles as targeted delivery of chrysin on human A549 cells |
| - | in-vitro, | Lung, | A549 |
| 6139- | CHr, | Chrysin and its nanoformulations in cancer therapy: A systematic review of their radiosensitizing, phototherapy-enhancing potentials |
| - | Review, | Var, | NA |
| 6134- | CHr, | QC, | RT, | Comparative Pharmacokinetics and Safety of a Micellar Chrysin–Quercetin–Rutin Formulation: A Randomized Crossover Trial |
| - | Trial, | Nor, | NA |
| 6135- | CHr, | Chrysin as a Multifunctional Therapeutic Flavonoid: Emerging Insights in Pathogenesis Management: A Narrative Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6128- | CHr, | Chrysin: A Comprehensive Review of Its Pharmacological Properties and Therapeutic Potential |
| - | Review, | Nor, | NA | - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6123- | CHr, | Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms |
| - | Review, | Nor, | NA |
| 6122- | CHr, | Disposition and metabolism of the flavonoid chrysin in normal volunteers |
| - | Human, | Nor, | NA |
| 2780- | CHr, | Anti-cancer Activity of Chrysin in Cancer Therapy: a Systematic Review |
| - | Review, | Var, | NA |
| 2781- | CHr, | PBG, | Chrysin a promising anticancer agent: recent perspectives |
| - | Review, | Var, | NA |
| 2782- | CHr, | Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 2784- | CHr, | Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review) |
| - | Review, | Var, | NA |
| 2785- | CHr, | Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin |
| - | Review, | Var, | NA |
| 2787- | CHr, | Network pharmacology unveils the intricate molecular landscape of Chrysin in breast cancer therapeutics |
| - | Analysis, | Var, | MCF7 |
| 2788- | CHr, | Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action |
| - | Review, | Var, | NA |
| 2790- | CHr, | Chrysin: Pharmacological and therapeutic properties |
| - | Review, | Var, | NA |
| 6145- | Cin, | Cinnamaldehyde microcapsules enhance bioavailability and regulate intestinal flora in mice |
| - | in-vivo, | Nor, | NA |
| 6141- | Cin, | The role and mechanism of cinnamaldehyde in cancer |
| - | Review, | Var, | NA |
| 6140- | Cin, | HCAs, | Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review) |
| - | Review, | Var, | NA |
| 9000- | Citicoline, | The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives |
| - | Review, | AD, | NA |
| - | in-vitro, | Colon, | Caco-2 |
| 4769- | CoQ10, | CoQ10 Is Key for Cellular Energy and Cancer Support |
| - | Review, | Var, | NA |
| 3997- | CoQ10, | Coenzyme Q and Its Role in the Dietary Therapy against Aging |
| - | Review, | AD, | NA |
| 5810- | CPT, | CPT-11, | Camptothein-Based Anti-Cancer Therapies and Strategies to Improve Their Therapeutic Index |
| - | Review, | Var, | NA |
| 5809- | CPT, | Cancer Therapies Utilizing the Camptothecins: A Review of in Vivo Literature |
| - | Review, | Var, | NA |
| 9274- | CRAN, | Absorption, Metabolism and Excretion of Cranberry (Poly)phenols in Humans: A Dose Response Study and Assessment of Inter-Individual Variability |
| - | Trial, | Nor, | NA |
| 6181- | Cro, | Crocetin: A Systematic Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6180- | Cro, | New findings in the metabolism of the saffron apocarotenoids, crocins and crocetin, by the human gut microbiota |
| - | Study, | Nor, | NA |
| 6311- | Cro, | Intestinal Metabolism of Crocin and a Pharmacokinetics and Pharmacodynamics Study in the Chronic Social Defeat Stress Mouse Model |
| - | in-vivo, | Nor, | NA |
| 6310- | Cro, | Characterization of Crocetin Isomers in Serum Samples via UHPLC-DAD-MS/MS and NMR after Saffron Extract (Safr’Inside™) Consumption |
| - | in-vivo, | Nor, | NA |
| 6307- | Cro, | Effects of Intestinal Microbiota on Pharmacokinetics of Crocin and Crocetin in Male Sprague-Dawley Rats |
| - | in-vivo, | Nor, | NA |
| 6296- | Cro, | Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats |
| - | in-vivo, | Nor, | NA |
| 6295- | Cro, | Bioaccessibility and Pharmacokinetics of a Commercial Saffron (Crocus sativus L.) Extract |
| - | Human, | Nor, | NA |
| 3635- | Cro, | A Review of Potential Efficacy of Saffron (Crocus sativus L.) in Cognitive Dysfunction and Seizures |
| - | Review, | AD, | NA |
| 7417- | CS, | CGA, | Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans |
| - | Trial, | Nor, | NA |
| 7427- | CS, | Poly, | Polyphenols from artichoke heads (Cynara cardunculus (L.) subsp. scolymus Hayek): in vitro bio-accessibility, intestinal uptake and bioavailability |
| - | Study, | Nor, | NA |
| 1602- | Cu, | A simultaneously GSH-depleted bimetallic Cu(ii) complex for enhanced chemodynamic cancer therapy† |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | 4T1 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Liver, | HepG2 |
| 6194- | Cuc, | Pharmacokinetics of cucurbitacin B from Trichosanthes cucumerina L. in rats |
| - | in-vivo, | Nor, | NA |
| 6195- | Cuc, | Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends |
| - | Review, | Var, | NA |
| 6185- | Cuc, | Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA |
| 6198- | Cuc, | Comparison of the pharmacokinetic profiles of three triterpenoids after oral administration of a cucurbitacin tablet and nanosuspension by UHPLC-MS/MS |
| - | in-vivo, | Nor, | NA |
| 6201- | Cuc, | Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6205- | CUR, | Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis |
| - | Review, | Var, | NA |
| 3588- | CUR, | The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies |
| - | Review, | AD, | NA |
| 3586- | CUR, | PI, | Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers |
| - | in-vivo, | Nor, | NA |
| 3585- | CUR, | Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer |
| - | Study, | Nor, | NA |
| 3582- | CUR, | PI, | Therapeutic and Preventive Effects of Piperine and its Combination with Curcumin as a Bioenhancer Against Aluminum-Induced Damage in the Astrocyte Cells |
| - | in-vivo, | Nor, | NA |
| 3579- | CUR, | AgNPs, | Metal–Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:792 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid